Publications by authors named "Maria G Donday"

Claim this Profile
W
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.
Javier P Gisbert, María G Donday, Sabino Riestra, Alfredo J Lucendo, José-Manuel Benítez

Gut· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a New Monoclonal Chemiluminescent Immunoassay Stool Antigen Test for the Diagnosis of Infection: A Spanish Multicentre Study.
Elena Resina, María G Donday, Samuel J Martínez-Domínguez, Emilio José Laserna-Mendieta, Ángel Lanas

J Clin Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU.
María Chaparro, María G Donday, Francisco Abad-Santos, Francisco Javier Martín de Carpi, Miguel Ángel Maciá-Martínez

Therap Adv Gastroenterol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
María Chaparro, Jordi Gordillo, Eugeni Domènech, Maria Esteve, Manuel Barreiro-de Acosta, María G Donday

Am J Gastroenterol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection.
Adrian G McNicholl, Ana Garre, Laura Llorca, Luis Bujanda, Javier Molina-Infante, Maria G Donday

Gastroenterol Hepatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.
Adrian G McNicholl, Dmitry S Bordin, Alfredo Lucendo, Galina Fadeenko, Manuel Castro Fernandez, Maria G Donday

Clin Gastroenterol Hepatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial.
María Chaparro, María G Donday, Manuel Barreiro-de Acosta, Eugeni Domènech, María Esteve

Therap Adv Gastroenterol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
María Chaparro, Manuel Barreiro-de Acosta, Ana Echarri, Rosendo Almendros, Jesús Barrio, María G Donday

Dig Dis Sci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helicobacter Pylori Treatment Results in Slovenia in the Period 2013-2015 as a Part of European Registry on Helicobacter Pylori Management.
Bojan Tepes, Marko Kastelic, Miroslav Vujasinovic, Polona Lampic, Maja Seruga, Maria G Donday

Radiol Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
Mercedes Ramas, Maria G Donday, Adrian G McNicholl, Javier P Gisbert

Gastroenterol Hepatol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis